![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
TGFβ biology in cancer progression and immunotherapy
TGFβ signalling has key roles in cancer progression: most carcinoma cells have inactivated their epithelial antiproliferative response and benefit from increased TGFβ expression and autocrine TGFβ signalling t...
-
Article
Erratum: Targeting the TGFβ signalling pathway in disease
Nature Reviews Drug Discovery 11, 790–811 (2012) On page 7 of the main text, LY2382770 was incorrectly referred to as a pan-TGFβ ligand-specific blocking antibody; it is a TGFβ1 ligand-selective blocking antib...
-
Article
Erratum: Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia
Nature Communications 3: Article number: 616 (2012); Published: 10 January 2012; Updated: 23 October 2012. This article contains four typographical errors in the abstract. Hereditary haemorrhagic telangiectasi...
-
Article
Targeting the TGFβ signalling pathway in disease
Transforming growth factor-β (TGFβ) has pleiotropic effects on many cell types in vivo, mediated via multiple signalling pathways — canonical and non-canonical
-
Article
The paradoxical TGF-β vasculopathies
Two new studies show that haploinsufficiency for TGFB2 causes a familial syndrome of thoracic aortic aneurysms and dissections with other clinical features that overlap the Marfan, Loeys-Dietz spectrum of syndrom...
-
Article
Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia
Hereditary haemorrhagic telangiectasia (HTT) is a vascular dysplasia syndrome caused by mutations in transforming growth factor-β/bone morphogenetic protein pathway genes, ENG and ACVRL1. HTT shows considerable v...
-
Article
Taking thalidomide out of rehab
Thalidomide, a drug reviled in the 1960s for its teratogenic effects, has been revived in recent years for cancer and leprosy therapy. A study now finds another use for this drug in vascular disease, providing...
-
Article
Transforming growth factor-β in breast cancer: too much, too late
The contribution of transforming growth factor (TGF)β to breast cancer has been studied from a myriad perspectives since seminal studies more than two decades ago. Although the action of TGFβ as a canonical tu...
-
Article
The type I TGF-β receptor is covalently modified and regulated by sumoylation
Post-translational sumoylation, the covalent attachment of a small ubiquitin-like modifier (SUMO), regulates the functions of proteins engaged in diverse processes. Often associated with nuclear and perinuclea...
-
Article
Differentiation plasticity regulated by TGF-β family proteins in development and disease
During development, stem and progenitor cells gradually commit to differentiation pathways. Cell fate decisions are regulated by differentiation factors, which activate transcription programmes that specify li...
-
Article
A sweet link between TGFβ and vascular disease?
Mutations in SCL2A10, encoding a glucose transporter, result in arterial tortuosity syndrome, indicating a link between glucose metabolism and angiopathic changes. Intriguingly, some of the phenotypic effects of
-
Article
TGFβ signaling in health and disease
Inactivating mutations in TGFBR2, encoding the transforming growth factor-β (TGFβ) type 2 receptor, may account for up to 10% of cases of Marfan syndrome. This finding has implications for a wider spectrum of dis...
-
Article
Dangerous liaisons
The cells of multicellular organisms are highly communicative and so can strongly influence one another's behaviour. One line of communication is particularly important in kee** cell growth in check.
-
Article
Metastasis is driven by sequential elevation of H-ras and Smad2 levels
Metastasis is a multistep process that involves local tumour invasion followed by dissemination to, and re-establishment at, distant sites. Here we show that during multistage tumorigenesis, discrete expressio...
-
Article
TGF-β signaling in tumor suppression and cancer progression
Epithelial and hematopoietic cells have a high turnover and their progenitor cells divide continuously, making them prime targets for genetic and epigenetic changes that lead to cell transformation and tumorig...
-
Article
Map** of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice
The transforming growth factor β1 (TGFβ1) signalling pathway1,2 is important in embryogenesis3 and has been implicated in hereditary haemorrhagic telangiectasia (HHT)4,5, atherosclerosis6,7, tumorigenesis8,9 and ...
-
Chapter
Transforming growth factor ßs and cardiac development
Most studies of the action of growth factors on the cardiovascular system, and of the endogenous growth factor synthetic profiles of cardiac myocytes, endothelial cells and fibroblasts, have focused on tissues...
-
Article
Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis
Tumour promoters induce a wide spectrum of morphological and biochemical alterations when applied to mouse epidermis in vivo1. These include the induction of RNA (ref. 2), DNA (refs 3, 4) and protein synthesis5,...